Speaker illustration

Doctor Matthew Barrett

University College Dublin, Dublin (Ireland)

Effect of sacubitril/valsartan therapy on risk stratification biomarkers in a real-world heart failure population

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Natriuretic peptides

Session: Biomarkers

Thumbnail

Use of sacubitril/valsartan in a dedicated heart failure centre - real world experience from the first 110 patients

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Chronic Ischaemic heart disease

Session: Chronic heart failure

Thumbnail

IVC analysis - a reproducible and clinically relevant metric which deserves greater prominence in heart failure management

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Diuretics

Session: Chronic heart failure

Thumbnail

Eosinophilic myocarditis in patients on dobutamine therapy: an underappreciated but not uncommon phenomenon

Event: ESC Congress 2016

Topic: Medical aspects of transplantation

Session: Cardiomyopathies

Thumbnail

ESC 365 is supported by